Pharmacological Characterization of a New, Orally Active and Potent Allosteric Metabotropic Glutamate Receptor 1 Antagonist, 4-[1-(2-Fluoropyridin-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide (FTIDC)
2007 ◽
Vol 321
(3)
◽
pp. 1144-1153
◽
1997 ◽
Vol 40
(4)
◽
pp. 528-537
◽
2000 ◽
Vol 43
(25)
◽
pp. 4893-4909
◽
2009 ◽
Vol 77
(7)
◽
pp. 1246-1253
◽
2007 ◽
Vol 323
(1)
◽
pp. 147-156
◽
1995 ◽
Vol 7
(4)
◽
pp. 622-629
◽
1997 ◽
Vol 40
(19)
◽
pp. 3119-3129
◽
2000 ◽
Vol 394
(1)
◽
pp. 17-26
◽